JP2016535019A5 - - Google Patents

Download PDF

Info

Publication number
JP2016535019A5
JP2016535019A5 JP2016525563A JP2016525563A JP2016535019A5 JP 2016535019 A5 JP2016535019 A5 JP 2016535019A5 JP 2016525563 A JP2016525563 A JP 2016525563A JP 2016525563 A JP2016525563 A JP 2016525563A JP 2016535019 A5 JP2016535019 A5 JP 2016535019A5
Authority
JP
Japan
Prior art keywords
adenosine
pain
methyl
group
bromothien
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016525563A
Other languages
English (en)
Japanese (ja)
Other versions
JP6534997B2 (ja
JP2016535019A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/061734 external-priority patent/WO2015061426A1/en
Publication of JP2016535019A publication Critical patent/JP2016535019A/ja
Publication of JP2016535019A5 publication Critical patent/JP2016535019A5/ja
Application granted granted Critical
Publication of JP6534997B2 publication Critical patent/JP6534997B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016525563A 2013-10-23 2014-10-22 神経変性疾患及び疼痛の予防及び治療における使用のための化合物 Active JP6534997B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361894699P 2013-10-23 2013-10-23
US61/894,699 2013-10-23
PCT/US2014/061734 WO2015061426A1 (en) 2013-10-23 2014-10-22 Compounds for use in prevention and treatment of neurodegenerative diseases and pain

Publications (3)

Publication Number Publication Date
JP2016535019A JP2016535019A (ja) 2016-11-10
JP2016535019A5 true JP2016535019A5 (https=) 2017-11-09
JP6534997B2 JP6534997B2 (ja) 2019-06-26

Family

ID=52993493

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016525563A Active JP6534997B2 (ja) 2013-10-23 2014-10-22 神経変性疾患及び疼痛の予防及び治療における使用のための化合物

Country Status (14)

Country Link
US (1) US10301348B2 (https=)
EP (1) EP3060566B1 (https=)
JP (1) JP6534997B2 (https=)
KR (1) KR102313314B1 (https=)
CN (1) CN106414456B (https=)
AU (1) AU2014340114B2 (https=)
BR (1) BR112016008901B1 (https=)
CA (1) CA2927699C (https=)
IL (1) IL245103B (https=)
MX (1) MX367707B (https=)
RU (1) RU2695358C2 (https=)
SG (1) SG11201603063WA (https=)
WO (1) WO2015061426A1 (https=)
ZA (1) ZA201603118B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10675293B2 (en) * 2015-05-29 2020-06-09 The Board Of Trustees Of The Leland Stanford Junior University Nucleoside agents for the reduction of the deleterious activity of extended nucleotide repeat containing genes
US11753432B2 (en) 2017-01-27 2023-09-12 Academia Sinica Compound with analgesic effect for use in prevention and treatment of pain
EP4476235A4 (en) * 2022-02-10 2026-02-18 Academia Sinica METHOD FOR TREATMENT OF A SPINAL CORD INJURY AND CORRESPONDING COMPOSITION
TWI910441B (zh) * 2022-07-07 2026-01-01 中央研究院 治療思覺失調症之方法及用於其中之組成物
CA3275345A1 (en) * 2022-12-29 2024-07-04 Academia Sinica METHODS FOR TREATING SLEEP DISORDERS AND COMPOSITION INTENDED FOR USE THEREOF
TW202500138A (zh) * 2023-03-17 2025-01-01 中央研究院 治療結節性硬化症或癲癇之方法及用於其中之組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8274187A (en) 1986-10-31 1988-05-25 Warner-Lambert Company Heteroaromatic derivatives of adenosine
US5034381A (en) * 1988-01-07 1991-07-23 Ciba-Geigy Corporation 2-(substituted amino) adenosines as antihypertensives
SG80526A1 (en) * 1990-09-25 2001-05-22 Rhone Poulenc Rorer Int Compounds having antihypertensive and anti- ischemic properies
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
UY27939A1 (es) * 2002-08-21 2004-03-31 Glaxo Group Ltd Compuestos
US20120295863A1 (en) * 2009-11-13 2012-11-22 Yun-Lian Lin Dual-Action Compounds Targeting Adenosine A2A Receptor and Adenosine Transporter for Prevention and Treatment of Neurodegenerative Diseases
CA2783859A1 (en) * 2009-12-10 2011-06-16 Institute Of Materia Medica, Chinese Academy Of Medical Sciences N6-substituted adenosine derivatives and n6-substituted adenine derivatives and uses thereof
WO2013120076A1 (en) 2012-02-09 2013-08-15 Brand Bumps, LLC Decorative detectable warning panel having improved grip
US20150038445A1 (en) * 2012-02-11 2015-02-05 Academia Sinica Methods and compositions for treating pain

Similar Documents

Publication Publication Date Title
JP2016535019A5 (https=)
CA2813183C (en) Morpholino nucleic acid derivatives
CN106458901A (zh) 用于制备稠合杂环化合物的方法
JP2017538712A5 (https=)
JP2015051994A5 (https=)
JP2016536316A5 (https=)
EP3083630B1 (en) Process methods for phosphatidylinositol 3-kinase inhibitors
JP2016503391A5 (https=)
EP3653628B1 (en) Methods of preparing cytotoxic benzodiazepine derivatives
JP2015508092A5 (https=)
JP2018502077A5 (https=)
JP2015129106A5 (https=)
RU2016118282A (ru) Соединения для предотвращения и лечения нейродегенеративных заболеваний и боли
EP3083580A1 (en) A process for preparation of trelagliptin succinate
KR20170129264A (ko) 글리코시드 화합물의 제조 방법
WO2014083512A1 (en) Process for preparation of abiraterone acetate
JP2021500354A5 (https=)
JP2019525900A5 (https=)
CN102958931B (zh) 碳环核苷和其中使用的中间体的合成方法
KR20190020674A (ko) 포스포로디아미데이트 모르폴리노 올리고머의 제조 방법
JP2018515527A5 (https=)
JP2014516968A5 (https=)
CN107074858A (zh) 制备(2s,5r)‑6‑(苄氧基)‑7‑氧代‑1,6‑二氮杂二环[3.2.1]辛烷‑2‑羧酸钠的方法
US20180258091A1 (en) Process for manufacture of forodesine
JP2010517998A5 (https=)